夜线

Law Legalizing Medical Cannabis Enters Into Force in Switzerland_我的网站

A |     Previously patients were required to receive authorization for cannabis-based medicines from the Federal Office of Public Health. The new regulation will make it easier for people with chronic illnesses and pain to receive timely treatment, without having to go through tiring administrative procedures. Although, the authorities have not found sufficient evidence to reimburse cannabis-based medicines through the compulsory healthcare insurance, allowing their reimbursements only in exceptional cases.,The cultivation and production of cannabis for medical purposes will be controlled by the state's medical watchdog, Swissmedic, which will act in accordance with the UN Single Convention on Narcotic Drugs of 1961.,Any use or selling of cannabis for non-medical purposes is still prohibited in the country.。

B |     获悉，燧原科技公告，公司首次公开发行股票并在科创板上市，拟发行4303.5173万股，占发行后总股本10%，发行后总股本4.30亿股。本次发行采用战略配售、网下发行与网上发行相结合方式，初始战略配售860.7034万股，网下初始发行2754.2639万股，网上初始发行688.55万股。初步询价日为8月28日，网上网下申购日为9月2日。公司尚未盈利，如上市时仍未盈利将纳入科创成长层。保荐人为中信证券，联席主承销商为国泰海通证券和广发证券。原文链接。

C |

Current article:http://www.xiongpeiduanlouduoennongleng.cyou/ih98v/20260826/4820541.ppt

Published on:07:39:07